ALEXANDRIA, Va., June 16 -- United States Patent no. 12,653,906, issued on June 16.

"Damage-targeted treatments of disease" was invented by Erlinda M. Gordon (Santa Monica, Calif.) and Frederick L. Hall (Carmel Valley, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Methods of treating viral infectious diseases such as coronavirus disease 2019 and other diseases causing organ damage in a subject are provided.Treatments include administration of a targeted retrovector to the subject. Among the effects of these treatments is the lessening or prevention of complications of the disease, particularly those arising from pathogenic immune responses."

The patent was filed on Oct. 28, 2022, under Application N...